Publications by authors named "Lisa Willits"

Claim this Profile
A
An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease.
David A Lomas, David A Lipson, Bruce E Miller, Lisa Willits, Oliver Keene

J Clin Pharmacol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reported pneumonia in patients with COPD: findings from the INSPIRE study.
Peter M A Calverley, Robert A Stockley, Terence A R Seemungal, Gerry Hagan, Lisa R Willits

Chest· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience.
Bartolome Celli, Jörgen Vestbo, Christine R Jenkins, Paul W Jones, Gary T Ferguson, Lisa R Willits

Am J Respir Crit Care Med· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular events in patients with COPD: TORCH study results.
Peter M A Calverley, Julie A Anderson, Bartolome Celli, Gary T Ferguson, Christine Jenkins, Lisa R Willits

Thorax· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.
Gary T Ferguson, Peter M A Calverley, Julie A Anderson, Christine R Jenkins, Paul W Jones, Lisa R Willits

Chest· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study.
Christine R Jenkins, Paul W Jones, Peter M A Calverley, Bartolome Celli, Julie A Anderson, Lisa R Willits

Respir Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yes, steroids are safe in infants with asthma-like symptoms.
Hans Bisgaard, David Allen, J Milanowski, I Kalev, Lisa Willits

Pediatrics· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing.
Hans Bisgaard, David Allen, Janusz Milanowski, Ilia Kalev, Lisa Willits

Pediatrics· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Withdrawal from treatment as an outcome in the ISOLDE study of COPD.
Peter M A Calverley, Sally Spencer, Lisa Willits, P Sherwood Burge, Paul W Jones

Chest· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis